In Silico Prediction of the Phosphorylation of NS3 as an Essential Mechanism for Dengue Virus Replication and the Antiviral Activity of Quercetin

被引:6
|
作者
Alomair, Lamya [1 ,2 ,3 ]
Almsned, Fahad [2 ,3 ,4 ]
Ullah, Aman [2 ,3 ]
Jafri, Mohsin S. [2 ,3 ,5 ]
机构
[1] King Abdullah Int Med Res Ctr, Dept Biostat & Bioinformat, Bioinformat Sect, Riyadh 11481, Saudi Arabia
[2] George Mason Univ, Sch Syst Biol, Manassas, VA 22030 USA
[3] George Mason Univ, Krasnow Inst Adv Study, Manassas, VA 22030 USA
[4] King Fahad Specialist Hosp Dammam, Dammam 32253, Saudi Arabia
[5] Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, Baltimore, MD 21201 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 10期
基金
美国国家卫生研究院;
关键词
dengue; NS3; phosphorylation; quercetin; NS2B-NS3 PROTEASE INHIBITION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; FLAVIVIRUS; PROTEINS; HELICASE; LIGAND; SUBSTRATE; RESIDUES;
D O I
10.3390/biology10101067
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary:& nbsp;Dengue is a mosquito-borne virus that infects up to 400 million people worldwide annually. Dengue infection triggers high fever, severe body aches, rash, low platelet count, and could lead to Dengue hemorrhagic fever (DHF) in some cases. There is currently no cure, nor a broadly effective vaccine. The interaction of two viral proteins, nonstructural Proteins 3 and 5 (NS3 and NS5), is required for viral replication in the infected host's cells. Our computational modeling of NS3 suggested that phosphorylation of a serine residue at position 137 of NS3 by a specific c-Jun N-terminal kinase (JNK) enhances viral replication by increasing the interaction of NS3 and NS5 through structural changes in amino acid residues 49-95. Experimental studies have shown that inhibition of JNK prevents viral replication and have suggested that the plants' flavonoid Quercetin, Agathis flavone, and Myricetin inhibit Dengue infection. Our molecular simulations revealed that Quercetin binds NS3 and obstructs serine 137 phosphorylation, which may decrease viral replication. This work offers a molecular mechanism that can be used for anti-Dengue drug development.</p> & nbsp;</p> Dengue virus infection is a global health problem for which there have been challenges to obtaining a cure. Current vaccines and anti-viral drugs can only be narrowly applied in ongoing clinical trials. We employed computational methods based on structure-function relationships between human host kinases and viral nonstructural protein 3 (NS3) to understand viral replication inhibitors' therapeutic effect. Phosphorylation at each of the two most evolutionarily conserved sites of NS3, serine 137 and threonine 189, compared to the unphosphorylated state were studied with molecular dynamics and docking simulations. The simulations suggested that phosphorylation at serine 137 caused a more remarkable structural change than phosphorylation at threonine 189, specifically located at amino acid residues 49-95. Docking studies supported the idea that phosphorylation at serine 137 increased the binding affinity between NS3 and nonstructural Protein 5 (NS5), whereas phosphorylation at threonine 189 decreased it. The interaction between NS3 and NS5 is essential for viral replication. Docking studies with the antiviral plant flavonoid Quercetin with NS3 indicated that Quercetin physically occluded the serine 137 phosphorylation site. Taken together, these findings suggested a specific site and mechanism by which Quercetin inhibits dengue and possible other flaviviruses.</p>
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Dengue virus protein NS3 activates hexokinase activity in hepatocytes to support virus replication
    Figl, Marianne
    Jacquemin, Clemence
    Perrin-Cocon, Laure
    Andre, Patrice
    Lotteau, Vincent
    Diaz, Olivier
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E805 - E806
  • [2] Targeting the protease activity of Dengue virus NS3
    Yin, Zheng
    Lim, Siew Pheng
    Patel, Sejal
    Patel, Viral
    Beer, David
    Ma, Ngai Ling
    Vasudevan, Subhash
    Keller, Thomas
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 251 - 251
  • [3] Bluetongue Virus Nonstructural Protein NS3/NS3a Is Not Essential for Virus Replication
    van Gennip, Rene G. P.
    van de Water, Sandra G. P.
    van Rijn, Piet A.
    PLOS ONE, 2014, 9 (01):
  • [4] Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus
    Rahman, Md. Mahbubur
    Biswas, Sourav
    Islam, Kazi Jahidul
    Paul, Archi Sundar
    Mahato, Shiplob Kumar
    Ali, Md. Ackas
    Halim, Mohammad A.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 134
  • [5] Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase
    Byrd, Chelsea M.
    Grosenbach, Douglas W.
    Berhanu, Aklile
    Dai, Dongcheng
    Jones, Kevin F.
    Cardwell, Kara B.
    Schneider, Christine
    Yang, Guang
    Tyavanagimatt, Shanthakumar
    Harver, Chris
    Wineinger, Kristin A.
    Page, Jessica
    Stavale, Eric
    Stone, Melialani A.
    Fuller, Kathleen P.
    Lovejoy, Candace
    Leeds, Janet M.
    Hruby, Dennis E.
    Jordan, Robert
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1902 - 1912
  • [6] Molecular mechanism of the Dengue virus NS3/NS2b protease
    Lima, Maria Carolina
    Seabra, Gustavo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [7] Insights into the product release mechanism of dengue virus NS3 helicase
    Adler, Natalia S.
    Cababie, Leila A.
    Sarto, Carolina
    Cavasotto, Claudio N.
    Gebhard, Leopoldo G.
    Estrin, Dario A.
    Gamarnik, Andrea, V
    Arrar, Mehrnoosh
    Kaufman, Sergio B.
    NUCLEIC ACIDS RESEARCH, 2022, 50 (12) : 6968 - 6979
  • [8] Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus
    Rasool, Nouman
    Ashraf, Aisha
    Waseem, Muneeba
    Hussain, Waqar
    Mahmood, Sajid
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2019, 44 (03): : 261 - 277
  • [9] IN SILICO DRUG DESIGNING STUDIES ON DENGUE VIRUS NS2B/NS3 PROTEASE
    Sushmitha, H. S.
    Sathyamurthy, Balasubramanian
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7784 - 7790
  • [10] NS3 peptide, a novel potent hepatitis C virus NS3 helicase inhibitor:: Its mechanism of action and antiviral activity in the replicon system
    Gozdek, Agnieszka
    Zhukov, Igor
    Polkowska, Agnieszka
    Poznanski, Jaroslaw
    Stankiewicz-Drogon, Anna
    Pawowicz, Jerzy M.
    Zagorski-Ostoja, Wodzirnierz
    Borowski, Peter
    Boguszewska-Chachulska, Anna M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 393 - 401